Literature DB >> 23796358

Oxidative and antioxidative status of children with acute bronchiolitis.

Rusen Dundaroz1, Ufuk Erenberk, Ozden Turel, Aysegul Dogan Demir, Emin Ozkaya, Ozcan Erel.   

Abstract

OBJECTIVE: Oxidative stress has been shown to contribute to the pathogenesis of acute and chronic lung inflammatory diseases. This article aimed to evaluate the oxidant/antioxidant status of children with acute bronchiolitis through the measurement of plasma total antioxidant capacity, total oxidant status, and oxidative stress index.
METHODS: Children with acute bronchiolitis admitted to the pediatric emergency department of a university hospital between January and April of 2012 were compared with age-matched healthy controls. Patients with acute bronchiolitis were classified as mild and moderate bronchiolitis. Oxidative and antioxidative status were assessed by measurement of plasma total antioxidant capacity, total oxidant status, and oxidative stress index.
RESULTS: Thirty-one children with acute bronchiolitis aged between 3 months and 2 years, and 39 healthy children were included. Total oxidative status (TOS) was higher in patients with acute bronchiolitis than the control group (5.16±1.99 μmol H2O2 versus 3.78±1.78 μmol H2O2 [p=0.004]). Total antioxidant capacity (TAC) was lower in children with bronchiolitis than the control group (2.51±0.37 μmol Trolox eqv/L versus 2.75±0.39 μmol Trolox eqv/L [p=0.013]). Patients with moderate bronchiolitis presented higher TOS levels than those with mild bronchiolitis and the control group (p=0.03, p<0.001, respectively). Patients with moderate bronchiolitis had higher oxidative stress index levels than the control group (p=0.015). Oxygen saturation level of bronchiolitis patients was inversely correlated with TOS (r=-0.476, p<0.05).
CONCLUSION: The balance between oxidant and antioxidant systems is disrupted in children with moderate bronchiolitis, which indicates that this stress factor may have a role in the pathogenesis of the disease.
Copyright © 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Bronchiolitis; Bronquiolite; Estresse; Infant; Neonato; Oxidante; Oxidative; Stress

Mesh:

Substances:

Year:  2013        PMID: 23796358     DOI: 10.1016/j.jped.2012.12.001

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  5 in total

1.  Is oxidative stress related to childhood urolithiasis?

Authors:  Nilufer Göknar; Faruk Oktem; Engin Arı; Aysegul Doğan Demir; Emel Torun
Journal:  Pediatr Nephrol       Date:  2014-02-14       Impact factor: 3.714

2.  Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis.

Authors:  Soner Sertan Kara; Ozcan Erel; Tugba Bedir Demirdag; Burcu Ceylan Cura Yayla; Belgin Gulhan; Salim Neselioglu; Meltem Polat; Gokhan Kalkan; Anil Tapisiz; Hasan Tezer
Journal:  Redox Rep       Date:  2016-04-20       Impact factor: 4.412

3.  Association of Nasopharyngeal and Serum Glutathione Metabolism with Bronchiolitis Severity and Asthma Risk: A Prospective Multicenter Cohort Study.

Authors:  Michihito Kyo; Zhaozhong Zhu; Makiko Nanishi; Ryohei Shibata; Tadao Ooka; Robert J Freishtat; Jonathan M Mansbach; Carlos A Camargo; Kohei Hasegawa
Journal:  Metabolites       Date:  2022-07-22

4.  Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis.

Authors:  Emel Torun; Ahmet Hakan Gedik; Erkan Cakir; Tarik Umutoglu; Ozlem Gok; Ulkan Kilic
Journal:  Med Princ Pract       Date:  2014-07-16       Impact factor: 1.927

5.  Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot study.

Authors:  Isabella Tarissi De Jacobis; Rosa Vona; Elisabetta Straface; Lucrezia Gambardella; Giulia Ceglie; Francesca de Gennaro; Ilenia Pontini; Anna Chiara Vittucci; Alessandra Carè; Camilla Cittadini; Alberto Villani; Donatella Pietraforte
Journal:  Ital J Pediatr       Date:  2020-03-06       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.